B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers.

Leukemia Research
M BengtssonT H Tötterman

Abstract

The reconstitution of B cells in the bone marrow and peripheral blood was prospectively studied in 27 patients undergoing autologous bone marrow transplantation (ABMT). No major differences in B cell regeneration patterns were recorded between patients receiving marrows purged of B cells (anti-CD10 + 19; n = 17) and patients receiving unpurged marrows (n = 10). Compared with healthy controls, elevated absolute and relative numbers of B cells were recorded in the blood and marrow at +6 and +12 months in both groups of patients. CD23+ B cells were severely depressed during the first three months post ABMT, indicating immaturity. A twofold increase in B cells carrying the activation marker 4F2 was recorded in the marrow at +1 month. Serum immunoglobulin levels (IgG, IgA, IgM) were within low-normal range throughout the study. The depressed B cell responses reported after allogeneic and autologous BMT could in part be explained by the low expression of the CD23 antigen on B cells after such therapy.

References

Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G R Guy, J Gordon
Feb 1, 1988·Immunology Today·A O'GarraJ Christiansen
Sep 1, 1986·British Journal of Haematology·M K BrennerH G Prentice
Mar 1, 1983·British Journal of Haematology·D C LinchR J Levinski
Jan 1, 1987·Immunology Today·J Gordon, G R Guy

❮ Previous
Next ❯

Citations

Nov 1, 1993·Cancer Immunology, Immunotherapy : CII·U N Verma, A Mazumder
Nov 1, 1995·British Journal of Haematology·N FarahatD Catovsky
Dec 22, 2012·Case Reports in Surgery·Riccardo MaglioRamacciato Giovanni
Oct 25, 2008·Seminars in Immunopathology·Jan StorekEddy Roosnek
Jul 1, 1993·European Journal of Pediatrics·K LeibundgutH P Wagner
Mar 31, 2010·Leukemia & Lymphoma·Charulata RamaprasadDavid L Pitrak
Feb 16, 2000·Leukemia & Lymphoma·J A García VelaF Oña
Nov 24, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Theodore HonebrinkMichael R Verneris
Oct 16, 2009·Cases Journal·Małgorzata PaulKrystyna Pecold
Sep 4, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Saro H ArmenianMinoo Battiwalla
Dec 15, 1994·Cytometry·T Lavabre-BertrandA Porwit-MacDonald
Oct 2, 2012·Journal of Gastroenterology and Hepatology·Winnie Yeo, Henry L Y Chan
Apr 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jay H Hoofnagle
Jun 6, 2013·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Osamu NagakawaToyohiko Yoshida

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.